Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Tekmira Pharmaceuticals Corp: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

28 Feb 2015 Reuters Investment Profile 12 $20.00

Arbutus Biopharma Corp: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

29 Aug 2015 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Arbutus Biopharma Corp (ABUS-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

02 Sep 2015 Thomson Reuters Stock Report 11 $25.00

ABUS: Due Diligence Review: Forensic Earnings and Valuation

Reports provide superior value and incorporate critical data from the Financial Footnotes and MD&A that other firms miss. The...

02 Sep 2015 New Constructs, LLC 10 $25.00

ValuEngine Rating and Forecast Report for ABUS

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

30 Aug 2015 ValuEngine, Inc. 11 $25.00

Value Graph: ARBUTUS BIOPHARM -- ABUS

28 Aug 2015 Ford Investor Services, Inc. 1 $12.00

Industry Value Graph: ABUS -- DRUGS

28 Aug 2015 Ford Investor Services, Inc. 3 $35.00

ValuEngine Industry Report for Medical-Biomed/Genetics(ABUS)

Advanced academic research that brings you superior investment strategies in an actionable format. Industry Analysis Report, ...

20 Aug 2015 ValuEngine, Inc. 10 $49.00

ABUS.OQ - Event Transcript of Arbutus Biopharma Corp conference call, Aug. 11, 2015 / 2:30PM ET

Edited Event Transcript of ABUS.OQ conference call, Aug. 11, 2015 / 2:30PM ET New York, Aug 28, 2015 (Thomson StreetEve...

11 Aug 2015 Thomson Reuters StreetEvents 8 $75.00

TKMR: Due Diligence Review: Forensic Earnings and Valuation

Reports provide superior value and incorporate critical data from the Financial Footnotes and MD&A that other firms miss. The...

03 Aug 2015 New Constructs, LLC 10 $25.00